Skip to main content
Clinical Trials/PACTR201412000967245
PACTR201412000967245
Not Yet Recruiting
Phase 1

Pharmacological enhancement of motor function recovery in patients with ischaemic stroke: a trial of fluoxetine.

dike franklin0 sites60 target enrollmentDecember 10, 2014
ConditionsStroke

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Stroke
Sponsor
dike franklin
Enrollment
60
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 10, 2014
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
dike franklin

Eligibility Criteria

Inclusion Criteria

  • (1\)18\- 85yrs of age
  • (2\)Ischaemic stroke, unilateral, supra\-tentorialconfirmed by neuroimaging.
  • (3\)Presentation within first 14 days of ictus
  • (4\)NIHSS score (5\)Hemiparesis or hemiplegia, FMMS (6\)Informed consent.

Exclusion Criteria

  • (1\) Glasgow coma score \< 8,
  • (2\) NIHSS score \>16
  • (3\)Cardiovascular/metabolic /respiratory instability\-: hypertensive emergency or hypotension/ acidosis or alkalosis/ RR \>24cycles per min.
  • (4\)Previous central /peripheral nerve injury
  • (5\)Concurrent medications interacting with SSRI¿s
  • (6\)Haemorrhagic stroke on CT
  • (7\)Substantial premorbid disability
  • (8\)Depression (Montgomery\-Åsberg Depression Rating Scale MADRS score \>19\), taking anti\-depressant drugs, MAOI, neuroleptic drugs or benzodiazepines during the month before inclusion.
  • (9\)Pregnancy.
  • (10\)No consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials